Skip to main content
Intensive Care Medicine Experimental
Fig. 1 | Intensive Care Medicine Experimental

Fig. 1

From: Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers

Fig. 1

Injury-associated immunosuppression in critically ill patients. Injury-associated immunosuppression (IAI) may develop in critical illness. IAI was shown to be of importance in cases of persistence for ≥ 2 days. Key future potential therapeutical options are listed. Monocytic HLA-DR expression (mHLA-DR, given in bound antibodies per cell) may serve as a global marker of IAI

Back to article page